Hayek Kallen Investment Management Buys Shares of 3,425 Globe Life Inc. $GL

Hayek Kallen Investment Management purchased a new position in Globe Life Inc. (NYSE:GL) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 3,425 shares of the company’s stock, valued at approximately $612,000.

Other large investors have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Globe Life by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after purchasing an additional 86,349 shares in the last quarter. BlackRock Inc. purchased a new stake in shares of Globe Life during the second quarter worth about $987,901,000. Invesco Ltd. raised its position in shares of Globe Life by 2.7% in the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock valued at $552,262,000 after purchasing an additional 102,445 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Globe Life by 10.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock worth $327,479,000 after purchasing an additional 217,331 shares in the last quarter. Finally, Morgan Stanley grew its position in Globe Life by 7.2% during the 4th quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock worth $260,176,000 after purchasing an additional 125,567 shares during the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. Morgan Stanley lifted their price objective on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research note on Monday, July 6th. Piper Sandler upped their target price on Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. Jefferies Financial Group raised their target price on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. Finally, Wells Fargo & Company boosted their price target on Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $191.67.

Insider Buying and Selling at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 25,650 shares of Globe Life stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of $178.58, for a total transaction of $4,580,577.00. Following the completion of the transaction, the chief financial officer owned 50,568 shares in the company, valued at approximately $9,030,433.44. This trade represents a 33.65% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO James Matthew Darden sold 50,000 shares of the business’s stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $182.43, for a total value of $9,121,500.00. Following the completion of the transaction, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at approximately $10,663,215.93. This trade represents a 46.10% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 151,908 shares of company stock worth $27,239,981. Insiders own 2.11% of the company’s stock.

Globe Life Stock Performance

Shares of NYSE GL opened at $175.78 on Friday. The company has a 50 day simple moving average of $178.72 and a two-hundred day simple moving average of $159.43. The stock has a market cap of $13.51 billion, a price-to-earnings ratio of 11.67 and a beta of 0.48. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the company earned $3.05 EPS. The firm’s revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, analysts predict that Globe Life Inc. will post 15.71 earnings per share for the current year.

Globe Life Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s dividend payout ratio (DPR) is currently 8.76%.

Globe Life declared that its Board of Directors has authorized a stock buyback plan on Monday, August 10th that allows the company to repurchase $2.50 billion in shares. This repurchase authorization allows the company to reacquire up to 17.7% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.